Monoclonal antibodies (mAbs) have been a key therapeutic option for non-communicable diseases for decades, and a small number of mAbs have helped treat infectious diseases, including COVID-19. The ...

Monoclonal antibodies (mAbs) are manufactured proteins that behave similarly to antibodies found naturally in the body. Researchers initially developed them for treating certain cancers but have now ...

Important adverse events included infusion-related and hypersensitivity reactions in 25 of 306 immunocompromised participants (8.2%) who received pemivibart and anaphylaxis in 4 of 623 participants (0 ...

Monoclonal antibodies are a type of biologic medication that can treat moderate to severe inflammatory bowel disease (IBD) by targeting specific inflammatory processes in your body. Your doctor might ...

We read with great interest the recent article by Tsai et al,1 which compared characteristics between primary neuromyelitis ...

Respiratory syncytial virus (RSV) is a common respiratory virus which usually causes mild, cold-like symptoms during the respiratory virus season. However, especially among young infants under six ...

Targeting pituitary adenylate cyclase–activating polypeptide (PACAP) is a new avenue for treating migraine. The efficacy and safety of intravenous Lu AG09222, a humanized monoclonal antibody directed ...

Scientists can circumvent these challenges and keep their research moving forward with Bio X Cell’s in vivo antibodies, which are formulated in preservative-free PBS, tested for pathogens and ...

Many people who oppose taking Covid-19 vaccines have cited concerns over the risks of using new technology to deal with a disease. But many of them are flocking to hospitals after having contracted ...

A single subcutaneous injection of an investigational monoclonal antibody was safe and effective in preventing malaria in children in Mali, according to results of the phase II Mali Malaria mAB trial.